Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    Cancer discovery · 2023
    MHMohamad Hamieh
    PMID: 36961206PMCID: PMC10068450DOIFirst author160 citations
  2. 2
    Nature cancer · 2024
    JDJedd D WolchokTMTaha MerghoubMHMohamad Hamieh
    PMID: 38503896PMCID: PMC11921049DOISenior author21 citations
  3. 3
    Frontiers in immunology · 2021
    MHMohamad Hamieh
    PMID: 34566953PMCID: PMC8456028DOIFirst author8 citations

Publications

32 publications

Funding

6 grantsView NIH portfolio on RePORTER ↗

Active

6 grants
  • KP
    Columbia University-Weill Cornell Medicine CFAR (CU-WCM CFAR)
    National Institute of Allergy and Infectious Diseases · 2026–2031 · via Columbia University
    P30AI191337-01A1
  • PI
    Interrogating and targeting co-inhibitory and co-stimulatory molecules in CAR T-cell Therapies
    National Cancer Institute · 2026–2031
    R37CA300795-01A1
  • MPI
    Autologous Lymph Node T Cells Engineered to Overcome Treatment Resistant Lung Cancer
    National Cancer Institute · 2026–2028
    R21CA317270-01
  • Co-I
    PICI Grant and Main Collaboration Agreement with Multiple Subprojects
    Parker Institute for Cancer Immunotherapy · 2024–2028
    PICI 235170-03
  • MPI
    Interrogating and Targeting ICANS in CAR T-Cell Therapies
    National Cancer Institute · 2026–2028
    R21CA307817-01A1
  • MPI
    Clinical and Translational Science Center - UL1
    National Center for Advancing Translational Sciences · 2022–2027
    UL1TR002384-06

News mentions

1 mentionView all WCM news ↗
  • Fall Grants Roundup
    September 24, 2026

    Weill Cornell Medicine researchers have received major new funding to support collaborative efforts spanning clinical trials, precision medicine and drug target discovery with the potential to improve outcomes for patients with challenging cancers.

Mentoring

2 menteesAll publications with mentees →